{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:28:31Z","timestamp":1793053711622,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,2]],"date-time":"2027-02-02T00:00:00Z","timestamp":1801526400000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA179115"],"award-info":[{"award-number":["R01 CA179115"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA092629"],"award-info":[{"award-number":["P50 CA092629"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euo.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:12:58Z","timestamp":1746173578000},"page":"156-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative Group"],"prefix":"10.1016","volume":"9","author":[{"given":"Sunny B.","family":"Nalavenkata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Vertosick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eldred-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Raghallaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"M\u00fcntener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yaxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Poyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jahnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ants","family":"Toi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeet","family":"Ghai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Ankerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behfar","family":"Ehdaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish I.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.02.007_b0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euo.2020.11.008","article-title":"Association between multiparametric magnetic resonance imaging of the prostate and oncological outcomes after primary treatment for prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Stabile","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2025.02.007_b0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.02.007_b0020","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1007\/s00330-024-10795-4","article-title":"PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI","volume":"34","author":"de Rooij","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2025.02.007_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239975","article-title":"Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: impact on diagnostic accuracy and inter-reader agreement","volume":"15","author":"Hotker","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.02.007_b0040","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1007\/s00330-019-06166-z","article-title":"The primacy of multiparametric MRI in men with suspected prostate cancer","volume":"29","author":"Richenberg","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2025.02.007_b0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41391-021-00417-1","article-title":"Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level","volume":"25","author":"Oerther","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.02.007_b0050","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1158\/1078-0432.CCR-10-1328","article-title":"The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group","volume":"16","author":"Vickers","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2025.02.007_b0055","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"10.1016\/j.euo.2025.02.007_b0060","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.euo.2025.02.007_b0065","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021."},{"key":"10.1016\/j.euo.2025.02.007_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cancers13020359","article-title":"Global trends of latent prostate cancer in autopsy studies","volume":"13","author":"Kimura","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2025.02.007_b0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.juro.2016.08.103","article-title":"Prostate specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies compared with Western cohorts","volume":"197","author":"Chen","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2022.01.028","article-title":"Racial disparities in prostate cancer: a complex interplay between socioeconomic inequities and genomics","volume":"531","author":"Lowder","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.euo.2025.02.007_b0090","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/aja.2010.137","article-title":"An overview of prostate diseases and their characteristics specific to Asian men","volume":"14","author":"Xia","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.euo.2025.02.007_b0095","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2214\/AJR.18.20571","article-title":"A systematic review of the existing Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) literature and subset meta-analysis of PI-RADSv2 categories stratified by Gleason scores","volume":"212","author":"Barkovich","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euo.2025.02.007_b0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.02.007_b0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2023.04.017","article-title":"Intra-practice urologist-level variation in targeted fusion biopsy outcomes","volume":"177","author":"Dhir","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.02.007_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euo.2020.02.005","article-title":"Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review","volume":"3","author":"Stabile","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00261-021-03377-1","article-title":"Second-opinion reads in prostate MRI: added value of subspecialty interpretation and review at multidisciplinary rounds","volume":"47","author":"Li","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.euo.2025.02.007_b0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.euf.2017.11.010","article-title":"Prostate magnetic resonance imaging interpretation varies substantially across radiologists","volume":"5","author":"Sonn","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.02.007_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111255","article-title":"Prostate MRI and image quality: the urologist's perspective","volume":"170","author":"Khan","year":"2024","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euo.2025.02.007_b0130","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231130","article-title":"Global variation in magnetic resonance imaging quality of the prostate","volume":"309","author":"Giganti","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.02.007_b0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2020.03.035","article-title":"Five-year outcomes of magnetic resonance imaging-based active surveillance for prostate cancer: a large cohort study","volume":"78","author":"Stavrinides","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.urology.2019.01.035","article-title":"The accuracy of prostate magnetic resonance imaging interpretation: impact of the individual radiologist and clinical factors","volume":"127","author":"Pickersgill","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.02.007_b0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.eururo.2017.02.026","article-title":"What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel","volume":"72","author":"Moldovan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","article-title":"Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis","volume":"78","author":"Sathianathen","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0155","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euo.2023.08.001","article-title":"Is there an impact of transperineal versus transrectal magnetic resonance imaging-targeted biopsy in clinically significant prostate cancer detection rate? A systematic review and meta-analysis","volume":"6","author":"Uleri","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.euf.2023.07.011","volume":"10","author":"Scuderi","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.02.007_b0165","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/cncr.34981","article-title":"The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy","volume":"129","author":"Gaffney","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.02.007_b0170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouviere","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0175","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bju.13814","article-title":"A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy","volume":"120","author":"van Leeuwen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.02.007_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.06.004","article-title":"The Stanford Prostate Cancer Calculator: development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer","volume":"39","author":"Wang","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235779","article-title":"Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy","volume":"15","author":"Sandeman","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.02.007_b0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","article-title":"PRECISION Study Group. Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial","volume":"3","author":"Giganti","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.007_b0195","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00330-021-08169-1","article-title":"Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial","volume":"32","author":"Giganti","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2025.02.007_b0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","article-title":"Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway","volume":"20","author":"Barrett","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2025.02.007_b0205","doi-asserted-by":"crossref","unstructured":"Dinneen E, Kasivisvanathan V, Giganti F, Allen C, Shaw G, Punwani S. Re: Multiparametric MRI is not sufficient for prostate cancer staging: a single institutional experience validated by a multi-institutional regional collaborative. Thenappan Chandrasekar, Andrew Denisenko, Vasil Mico and Colleagues. Urol Oncol 41 (2023) 355.e1-355.e8. Urol Oncol 2024;42:18\u20139.","DOI":"10.1016\/j.urolonc.2023.08.018"},{"key":"10.1016\/j.euo.2025.02.007_b0210","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.eururo.2012.12.057","article-title":"Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study","volume":"65","author":"Robertson","year":"2014","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:57:40Z","timestamp":1775681860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2588931125000471"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative Group","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}